The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Sat., Apr. 20, 5:34 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #23. LHC Group Deaconess HomeCare

Acquirer: LHC Group (LHCG)
Acquiree: Deaconess HomeCare
Details: LHC Group Inc. (NASDAQ: LHCG), a national provider of home health, hospice and comprehensive post-acute healthcare services, announced today that it has signed a definitive stock purchase agreement with BioScrip, Inc. (NASDAQ: BIOS) to purchase two of its operating subsidiaries, doing business as Deaconess HomeCare and Elk Valley Health Services, for $60 million. The transaction will add 33 locations in five states, increasing LHC Group's geographical footprint to 342 locations across 27 states. The transaction, which is expected to close by the end of the first quarter of 2014, subject to customary closing conditions, is anticipated to be accretive to LHC Group's 2014 earnings by between $0.05 and $0.10 per diluted share.

LHC Group provides post-acute health care services to its patients. Co.'s segments include: home health services, which include nursing, medically-oriented social services and physical, occupational, and speech therapy; hospice services, which include pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, and family bereavement counseling; home and community-based services, which include assistance with grooming, medication reminders, meal preparation, feeding, light housekeeping, respite care, transportation, and errand services; and facility-based services, which provided through its long-term acute care hospitals.

Open the LHCG Page at The Online Investor »

Company Name: 
LHC Group Inc
Stock buyback: 
LHCG buyback
Website: 
www.lhcgroup.com
Sector: 
Hospital & Medical Practitioners
 

Open the LHCG Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree LHCG Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.22 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
LHCG Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 23 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.